Currently, a phase 3 clinical trial program for retatrutide (TRIUMPH) is underway to assess its safety and efficacy in different obese patient populations, including those with obstructive sleep apnea (OSA), T2D, diagnosed cardiovascular disease, osteoarthritis, and others
The new approval allows Mounjaro to be used as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27-30 kg/m) with at least one weight-related comorbidity such as hypertension, dyslipidemia, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease
This dual incretin receptor agonist fundamentally recalibrates metabolic messaging controlling hunger signals, energy balance, and nutritional processing throughout your body
It even suggests personalized meal ideas based on preferences and dietary needs, helping users get enough protein and fiber without any hassle